Trial Profile

Effects of Nebivolol and Atenolol on Central Aortic Depression in Patients with Hypertension

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 12 Apr 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Nebivolol (Primary) ; Atenolol
Indications Essential hypertension; Hypertension
Focus Pharmacodynamics
Sponsors Laboratorios Menarini

Most Recent Events

01 Jun 2014 Status changed from recruiting to completed, according to results published in the Blood Pressure.
30 Aug 2011 EudraCT record identified as additional data source and relevant information added
30 Aug 2011 Status changed from completed to recruiting , as reported in the EudraCT record

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com